Rincon Bio

Oceanside, United States Founded: 2013 • Age: 13 yrs
Pre-clinical CRO for in vivo cancer efficacy studies using xenograft and syngeneic models.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 3 Services tracked
Competitors 4 Brand Intelligence

About Rincon Bio

Rincon Bio is a company based in Oceanside (United States) founded in 2013. It operates as a B2B. Rincon Bio offers products and services including Xenograft Studies, Syngeneic Studies, and Custom Study Designs. Rincon Bio operates in a competitive market with competitors including Certis Oncology Solutions, Xentech and Nanoligent, among others.

  • Headquarter Oceanside, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Rincon Bio

Rincon Bio offers a comprehensive portfolio of products and services, including Xenograft Studies, Syngeneic Studies, and Custom Study Designs.

Product name locked
Category locked
Primary

Implantation of human cancer cells into animals for drug efficacy evaluation.

Product name locked
Category locked
Locked

Use of same-species tumor lines in hosts for immuno-oncology drug testing.

Product name locked
Category locked
Locked

Tailored in vivo studies including fluorescent imaging and pharmacodynamics.

Funding Insights of Rincon Bio

Premium access

Detailed funding history for Rincon Bio

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Rincon Bio

Investments
Premium access

Investment portfolio details for Rincon Bio

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Rincon Bio

Premium access

Detailed financials for Rincon Bio

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Rincon Bio Comparisons

Rincon Bio Primary company
Description
Pre-clinical CRO for in vivo cancer efficacy studies using x...
Location
Oceanside, United States
Founded Year
2013
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Rincon Bio

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Rincon Bio

Rincon Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Certis Oncology Solutions, Xentech and Nanoligent, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Oncology-based in-vivo drug development services are provided.
Locked Locked Locked
Patient-derived xenograft models for preclinical oncology research are provided.
Locked Locked Locked
Preclinical services for oncology drug development are provided.
Premium access

Detailed competitors of Rincon Bio

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Rincon Bio

Premium access

Complete news archive for Rincon Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rincon Bio

Rincon Bio was founded in 2013.

Rincon Bio is headquartered in Oceanside, United States. It is registered at Oceanside, California, United States.

Rincon Bio is a contract research organization focused on performing xenograft and syngeneic studies for cancer drug testing. They use human cancer cells in immunocompromised animals for xenografts and same-species models for syngeneics, allowing efficacy assessments of anti-cancer drugs. Based in Lehi, Utah, USA, they serve pharma researchers globally with fast study initiation and competitive pricing. Their services include custom designs, tumor collection, and pharmacodynamic studies.

Rincon Bio's top competitors include Certis Oncology Solutions, Nanoligent and Xentech.

Rincon Bio offers Xenograft Studies, Syngeneic Studies, and Custom Study Designs.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available